LNSR

LENSAR, Inc.

7.08 USD

Last updated Sep 21, 08:53 UTC

Yesterday HIGH

$7.23

Yesterday LOW

$6.9

52w HIGH

$12.92

52w LOW

$4.95

EPS

0.10

PE

70.80

Next Earnings

Nov 5, 2026

Overview News Government Trades Fundamentals

LENSAR, Inc. stock is down -18.43% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 September’s closed higher than August.

Benzinga Newsdesk

Thu Aug 20, 2026

BTIG Maintains Buy on LENSAR, Raises Price Target to $10

BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $9 to $10.
Benzinga Newsdesk

Thu Aug 13, 2026

LENSAR shares are trading higher after the company reported better-than-expected Q2 financial results.
Benzinga Insights

Thu Aug 13, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI) shares moved
Benzinga Newsdesk

Thu Aug 13, 2026

BTIG Maintains Buy on LENSAR, Raises Price Target to $9

BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $7 to $9.
Benzinga Insights

Thu Aug 13, 2026

LENSAR Q2 2026 Earnings Call: Complete Transcript

LENSAR (NASDAQ:LNSR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Benzinga Insights

Thu Aug 13, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares increased by
Benzinga Newsdesk

Thu Aug 13, 2026

LENSAR Q2 EPS $0.10 Beats $(0.17) Estimate, Sales $16.495M Beat $14.650M Estimate

LENSAR (NASDAQ:LNSR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.17) by 162.5 percent. This is a 166.67 percent increase over losses of $(0.15) per share from the same
Benzinga Newsdesk

Fri May 29, 2026

Lensar Appoints Michael A. Rossi As Interim CFO Effective May 29, 2026

On May 25, 2026, the Board of Directors (the "Board") of LENSAR, Inc. (the "Company") appointed Michael A. Rossi to serve as the Company's Interim Chief Financial Officer and principal financial officer, effective as of
Benzinga Newsdesk

Fri May 8, 2026

LENSAR Q1 Sales $13.428M Miss $13.450M Estimate

LENSAR (NASDAQ:LNSR) reported quarterly sales of $13.428 million which missed the analyst consensus estimate of $13.450 million by 0.16 percent. This is a 5.16 percent decrease over sales of $14.159 million the same
Benzinga Newsdesk

Wed Apr 15, 2026

LENSAR's Thomas R. Staab, II To Resign As CFO Effective May 8, 2026; Co Commences Search For New Chief Financial Officer

On April 10, 2026, Thomas R. Staab, II, Chief Financial Officer of LENSAR, Inc. (the "Company"), notified the Company of his intention to resign from this position, effective May 8, 2026 (the "Transition Date"), to